A detailed history of State Of Wisconsin Investment Board transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 54,468 shares of KALV stock, worth $474,416. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,468
Previous 60,755 10.35%
Holding current value
$474,416
Previous $715,000 11.89%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$9.46 - $15.39 $59,475 - $96,756
-6,287 Reduced 10.35%
54,468 $630,000
Q2 2024

Aug 14, 2024

BUY
$10.35 - $12.49 $163,064 - $196,779
15,755 Added 35.01%
60,755 $715,000
Q1 2024

May 14, 2024

SELL
$11.07 - $16.04 $67,527 - $97,844
-6,100 Reduced 11.94%
45,000 $533,000
Q4 2023

Feb 12, 2024

SELL
$7.58 - $12.25 $173,582 - $280,525
-22,900 Reduced 30.95%
51,100 $625,000
Q3 2023

Nov 14, 2023

SELL
$8.95 - $11.35 $130,669 - $165,710
-14,600 Reduced 16.48%
74,000 $712,000
Q2 2023

Aug 14, 2023

SELL
$7.73 - $10.57 $107,447 - $146,923
-13,900 Reduced 13.56%
88,600 $797,000
Q1 2023

May 15, 2023

SELL
$6.3 - $8.39 $99,540 - $132,562
-15,800 Reduced 13.36%
102,500 $805,000
Q4 2022

Feb 14, 2023

BUY
$4.2 - $14.24 $248,098 - $841,171
59,071 Added 99.73%
118,300 $799,000
Q3 2022

Nov 14, 2022

SELL
$9.85 - $16.83 $149,434 - $255,327
-15,171 Reduced 20.39%
59,229 $859,000
Q2 2022

Aug 15, 2022

BUY
$8.16 - $15.1 $330,480 - $611,550
40,500 Added 119.47%
74,400 $732,000
Q1 2022

May 13, 2022

BUY
$11.2 - $16.97 $140,000 - $212,125
12,500 Added 58.41%
33,900 $500,000
Q4 2021

Feb 11, 2022

SELL
$12.36 - $18.28 $174,276 - $257,748
-14,100 Reduced 39.72%
21,400 $283,000
Q3 2021

Nov 12, 2021

BUY
$17.11 - $24.49 $61,596 - $88,164
3,600 Added 11.29%
35,500 $619,000
Q1 2021

May 17, 2021

BUY
$14.69 - $42.57 $170,404 - $493,812
11,600 Added 57.14%
31,900 $820,000
Q4 2020

Feb 03, 2021

BUY
$12.88 - $19.47 $261,464 - $395,241
20,300 New
20,300 $385,000
Q1 2020

May 06, 2020

SELL
$5.8 - $18.56 $101,500 - $324,800
-17,500 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$11.6 - $21.67 $203,000 - $379,225
17,500 New
17,500 $203,000

Others Institutions Holding KALV

About KalVista Pharmaceuticals, Inc.


  • Ticker KALV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,602,000
  • Market Cap $214M
  • Description
  • KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...
More about KALV
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.